---
title: "Zentalis Pharmaceuticals PAO and PFO Vincent Vultaggio Reports Disposal of Common Shares"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/275538961.md"
datetime: "2026-02-11T02:10:58.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/275538961.md)
  - [en](https://longbridge.com/en/news/275538961.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/275538961.md)
---

# Zentalis Pharmaceuticals PAO and PFO Vincent Vultaggio Reports Disposal of Common Shares

Vincent Vultaggio, PAO and PFO of Zentalis Pharmaceuticals Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zentalis Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002018766-26-000006), on February 10, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [ZNTL.US](https://longbridge.com/en/quote/ZNTL.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)

## Related News & Research

- [Should Positive Elsunersen Data And Relutrigine Priority Review Shift the Narrative for Praxis (PRAX) Investors?](https://longbridge.com/en/news/282419526.md)
- [15:51 ETFertilAI Secures World's First CE Mark for Predictive AI in Fertility Treatment Cycle Optimization](https://longbridge.com/en/news/282891575.md)
- [KALA BIO 10-K: Operating loss $39.16M; Net loss $26.98M](https://longbridge.com/en/news/282893053.md)
- [Revolution Medicines' experimental cancer pill helps improve survival in late-stage study](https://longbridge.com/en/news/282540793.md)
- [Lilly's obesity pill helps reduce cardiovascular risks in late-stage trial](https://longbridge.com/en/news/282987274.md)